Folic Acid + Methotrexate is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Folic Acid + Methotrexate is used -
Severe
Moderate
Mild
Common
Is the use of Folic Acid + Methotrexate safe for pregnant women?
Folic Acid + Methotrexate has many dangerous side effects in pregnant women. If you are pregnant, do not consume Folic Acid + Methotrexate without medical advice.
Is the use of Folic Acid + Methotrexate safe during breastfeeding?
Folic Acid + Methotrexate should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Folic Acid + Methotrexate on the Kidneys?
There can be some harmful effects on your kidneys after taking Folic Acid + Methotrexate. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Folic Acid + Methotrexate on the Liver?
Folic Acid + Methotrexate may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Folic Acid + Methotrexate on the Heart?
Folic Acid + Methotrexate may have mild side effects on the heart. Most people will never see any effect on the heart.
Folic Acid + Methotrexate should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Folic Acid + Methotrexate unless your doctor advises you to do so -
Is this Folic Acid + Methotrexate habit forming or addictive?
No, you will not get addicted to Folic Acid + Methotrexate.
Interaction between Food and Folic Acid + Methotrexate
Information is not available on the interaction of any foods with Folic Acid + Methotrexate, due to a lack of research on this.
Interaction between Alcohol and Folic Acid + Methotrexate
Taking Folic Acid + Methotrexate and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
Folate is required by the human body for the synthesis, repair, and methylation of DNA. It also acts as a cofactor for various biological processes. Folate plays an important role during cell division and is required during infancy and pregnancy. Folate is required for the synthesis of healthy red blood cells. Deficiency of folate can affect all these roles and can cause anemia thus Folic Acid + Methotrexate fulfills this deficiency and prevents from anemia.
Folic Acid + Methotrexate can be safely taken through the oral route or injectible. The drug is safe when taken in doses less than 1000 micrograms per day. You are advised to take Folic Acid + Methotrexate as per your doctor's instructions. Do not take it in more than the prescribed doses.
Self-medication can be dangerous to health, therefore, one should take Folic Acid + Methotrexate after consulting a doctor.
Folic Acid + Methotrexate should be taken at the same time, whether morning or night. It should be taken with a glass of water, with or without food.
Long-term oral use of Folic acid can be unsafe as it can cause stomach upset, gas, abdominal cramps, and diarrhea.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methotrexate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862-863
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 832-834